Alzheimer’s Disease Clinical Trials
Alzheimer’s affects millions of people worldwide every year. Together, we can work to create a world where no one has to suffer from this illness. But we can’t do it alone. We need volunteers to participate in clinical trials in order to aid in the development of new treatments. Scroll down to learn more about the clinical trials we offer.
About the ADEPT-2 Alzheimer’s Disease Study
ADEPT-2 is a 14-week clinical study that will evaluate
the safety and efficacy of KarXT, an oral medication,
for the treatment of psychosis associated with
Alzheimer’s disease.
Have mild to severe Alzheimer’s disease with
moderate to severe psychosis
Are between the ages of 55 and 90
Have a history of psychotic symptoms for at
least 2 months prior to screening
There is no cost or insurance required to participate in this study. For eligible participants, we may also provide:
- Compensation for patients and caregivers
- No-cost healthcare (labs, health screenings, psychiatric care)
- Transportation (or reimbursement for travel costs)
Participating in clinical research allows us to connect patients with innovative forms of care. Additionally, clinical research helps to advance medicine for generations to come.
Interested in volunteering for this study? Use the button below to apply, and a member of the clinical team will contact you to discuss the study further.
Have questions?
Our study team would be happy to speak with you regarding any questions or concerns you may have. Visit our FAQ page or contact us today!
Let’s keep in touch
Follow us on social for the latest updates!